TickerFactsScreenerDevelopers

Silexion Therapeutics Corp (SLXNW) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2023: -$4.53M2024: -$8.40M2025: -$10.82M-$10.82M
2023Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$10.82M-28.9%
2024-$8.40M-85.4%
2023-$4.53M—